re: kajun one of the asx200 poor performers this will go ok this...

re: kajun one of the asx200 poor performers this will go ok this year if you have been a follower like myself over 4 years you come to understand the value of this company IF it can get FDA approval for cancer drug, it is close but how close who knows but I look at it this way if a small article in a newspaper on a sunday can push the share more that 20% what can FDA approval of a cancer drug that may work to save lives push a price, this company is not like some overseas companies they want to make sure their product works with no side affects that is where my trust is and if I am wrong that is trading for you just move on . Still a big supporter of NRT